Articles tagged with: Office of Biostatistics
Additional Features »
Sylva Collins joined the FDA’s Office of Biostatistics in 2019 and has more than 30 years of drug development experience and biostatistics leadership.
Sylva Collins joined the FDA’s Office of Biostatistics in 2019 and has more than 30 years of drug development experience and biostatistics leadership.